The early detection of PM dysfunction can be facilitated by biomarkers such as matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-1 (TIMP-1), which are linked to peritoneal fibrosis. The gene discussed is TIMP1; the disease is Peritoneal Fibrosis.